Nina Isoherranen

Nina Isoherranen

Professor of Pharmaceutics, University of Washington
Verified email at u.washington.edu
Cited by 8880
Drug-drug interactions Drug metabolism cytochrome P450 retinoids PBPK
Joseph A. Ware

Joseph A. Ware

Senior Vice President, Clinical Pharmacology
Verified email at a2-ai.com
Cited by 8712
Translational Sciences Oncolgy Drug Development Quantitative Pharmacology PBPK QSP
James Gallo

James Gallo

University at Buffalo
Verified email at buffalo.edu
Cited by 8163
PK/PD PBPK quantitative systems pharmacology brain tumors anticancer drugs
Jeffrey Fisher

Jeffrey Fisher

ScitoVation
Verified email at scitovation.com
Cited by 7797
pbpk toxicology
Youssef Daali

Youssef Daali

HUG, Faculté de Médecine, Université de Genève, Faculté des Sciences, Ecole de …
Verified email at hcuge.ch
Cited by 7350
Médecine personnalisée PBPK DDI Pharmacogénétique transport
Gunnar Johanson

Gunnar Johanson

professor, karolinska institutet
Verified email at ki.se
Cited by 6523
Occupstional exposure limits risk assessment toxicology toxicokinetics PBPK
Georg Hempel

Georg Hempel

Professor für Klinische Pharmazie
Verified email at uni-muenster.de
Cited by 5745
pharmacokinetics paediatrics PbPk
Richard A Corley

Richard A Corley

Greek Creek Toxicokinetics Consulting, LLC
Verified email at pnnl.gov
Cited by 5371
Toxicology Pharmacokinetics PBPK Computational Fluid Dynamics Inhalation
Filippos Kesisoglou

Filippos Kesisoglou

Distinguished Scientist, Pharmaceutical Sciences, Merck & Co., Inc.
Verified email at merck.com
Cited by 4972
biopharmaceutics IVIVC pharmacokinetics bioequivalence PBPK
Tristan Maurer

Tristan Maurer

VP, Translational M&S, Medicine Design, Pfizer
Verified email at pfizer.com
Cited by 4462
Drug Discovery DMPK Quantitative Systems Pharmacology PBPK Data Science
1 - 10